Green Thumb Industries Inc banner
G

Green Thumb Industries Inc
CNSX:GTII

Watchlist Manager
Green Thumb Industries Inc
CNSX:GTII
Watchlist
Price: 9.55 CAD -3.44%
Market Cap: CA$2.2B

Relative Value

The Relative Value of one GTII stock under the Base Case scenario is hidden CAD. Compared to the current market price of 9.55 CAD, Green Thumb Industries Inc is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

GTII Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Multiples Across Competitors

GTII Competitors Multiples
Green Thumb Industries Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Green Thumb Industries Inc
CNSX:GTII
2.3B CAD 1.4 37.1 4.7 9.2
US
Eli Lilly and Co
NYSE:LLY
994.4B USD 15.3 48.2 32.5 34.5
US
Johnson & Johnson
NYSE:JNJ
571B USD 6.1 21.3 14.8 18.2
CH
Roche Holding AG
SIX:ROG
282.2B CHF 4.6 30 12.7 14.8
CH
Novartis AG
SIX:NOVN
231.1B CHF 5.3 21.2 13.1 16.8
UK
AstraZeneca PLC
LSE:AZN
215.7B GBP 5.1 31.7 15.1 22.2
US
Merck & Co Inc
NYSE:MRK
292.1B USD 4.5 16 10 11.7
DK
Novo Nordisk A/S
CSE:NOVO B
1.4T DKK 4.6 13.8 10.1 11.8
IE
Endo International PLC
LSE:0Y5F
218B USD 94 -74.6 333.1 835.4
US
Pfizer Inc
NYSE:PFE
153.4B USD 2.4 19.7 7.4 9.8
US
Bristol-Myers Squibb Co
NYSE:BMY
124.3B USD 2.6 17.6 6.9 8.8
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
G
Green Thumb Industries Inc
CNSX:GTII
Average EV/EBITDA: 41.8
4.7
-3%
N/A
US
Eli Lilly and Co
NYSE:LLY
32.5
18%
1.8
US
Johnson & Johnson
NYSE:JNJ
14.8
2%
7.4
CH
Roche Holding AG
SIX:ROG
12.7
5%
2.5
CH
Novartis AG
SIX:NOVN
13.1
9%
1.5
UK
AstraZeneca PLC
LSE:AZN
15.1
10%
1.5
US
Merck & Co Inc
NYSE:MRK
10
7%
1.4
DK
Novo Nordisk A/S
CSE:NOVO B
10.1
7%
1.4
IE
E
Endo International PLC
LSE:0Y5F
333.1
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.4
-4%
N/A
US
Bristol-Myers Squibb Co
NYSE:BMY
6.9
-13%
N/A